Rockwell Medical, Inc. provided earnings guidance for the year 2025. For the year, the company projects net sales to grow in the mid-to-high single digits in 2025 and beyond.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | -0.28% | -3.31% | -7.41% |
30/05 | Rockwell Medical, Inc. Promotes Tim Chole to Chief Commercial Officer | CI |
14/05 | Transcript : Rockwell Medical, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.41% | 53.05M | |
+42.60% | 748B | |
+32.99% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.70% | 245B | |
+8.60% | 211B | |
-4.38% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Rockwell Medical, Inc. Provides Earnings Guidance for the Year 2025